Intramolecular hydroaminations mediated by reductive mercuration or n-butyllithium to afford 3-methyl- and 3,4-dimethyl-1,2,3,4- tetrahydroisoquinolines

European Journal of Organic Chemistry

Volumn , Issue 32, 2007, Pages 5337-5345

  Pathak, Rakhi ^a   Naicker, Prevashni ^a   Thompson, Warren A ^a   Fernandes, Manuel A ^a   De Koning, Charles B ^a   Van Otterlo, Willem A L ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Hydroamination; n butyllithium; Reductive mercuration; Tetrahydroisoquinolines

Indexed keywords

EID: 36148989169     PISSN: 1434193X     EISSN: 10990690     Source Type: Journal    
DOI: 10.1002/ejoc.200700580     Document Type: Article

References (73)

1. For reviews on the hydroamination of alkenes and alkynes see: a) M. Beller, J. Seayad, A. Tillack, H. Jiao, Angew. Chem. Int. Ed. 2004, 43, 3368-3398;
2. b) F. Alonso, I. P. Beletskaya, M. Yus, Chem. Rev. 2004, 104, 3079-3159;
3. c) M. Beller, C. Breindl, M. Eichberger, C. G. Hartung, J. Seayad, O. R. Thiel, A. Tillack, H. Trauthwein, Synlett 2002, 1579-1594;
4. d) J. Seayad, A. Tillack, C. G. Hartung, M. Beller, Adv. Synth. Catal. 2002, 344, 795-813;
5. e) T. E. Müller, M. Beller, Chem. Rev. 1998, 98, 675-703.
6. A. Takemiya, J. F. Hartwig, J. Am. Chem. Soc. 2006, 128, 6042-6043.
7. a) M. C. Wood, D. C. Leitch, C. S. Yeung, J. A. Kozak, L. L. Schafer, Angew. Chem. Int. Ed. 2007, 46, 354-358 and references cited therein;
8. b) L. Ackerman, L. T. Kaspar, A. Althammer, Org. Biomol. Chem. 2007, 5, 1975-1978 and references cited therein;
9. c) P. D. Knight, I. Munslow, P. N. O'Shaughnessy, P. Scott, Chem. Commun. 2004, 894-895.
10. M. Dochnahl, J.-W. Pissarek, S. Blechert, K. Löhnwitz, P. W. Roesky, Chem. Commun. 2006, 3405-3407.
11. M. R. Crimmin, I. J. Casely, M. S. Hill, J. Am. Chem. Soc. 2005, 127, 2042-2043.
12. For a review see the following paper: a) S. Hong, T. J. Marks, Acc. Chem. Res. 2004, 37, 673-686;
13. b) M. Rastätter, A. Zulys, P. W. Roesky, Chem. Commun. 2006, 874-876;
14. c) A. Zulys, T. K. Panda, M. T. Gamer, P. W. Roesky, Chem. Commun. 2004, 2584-2585;
15. d) Y. K. Kim, T. Livinghouse, J. E. Bercaw, Tetrahedron Lett. 2001, 42, 2933-2935.
16. For a review see the following paper: a) K. C. Hultzch, Org. Biomol. Chem. 2005, 3, 1819-1824;
17. b) D. V. Gribkov, K. C. Hultzch, F. Hampel, J. Am. Chem. Soc. 2006, 128, 3748-3759;
18. c) D. Riegert, J. Collin, A. Meddour, E. Schulz, A. Trifonov, J. Org. Chem. 2006, 71, 2514-2517;
19. d) Y. K. Kim, T. Livinghouse, Angew. Chem. Int. Ed. 2002, 41, 3645-3647;
20. e) P. N. O'Shaughnessy, P. Scott, Tetrahedron: Asymmetry 2003, 14, 1979-1983;
21. f) P. N. O'Shaughnessy, P. D. Knight, C. Morton, K. M. Gillespie, P. Scott, Chem. Commun. 2003, 1770-1771;
22. g) P. W. Roesky, T. E. Müller, Angew. Chem. Int. Ed. 2003, 42, 2708-2710.
23. a) D. Kadzimirsz, D. Hildebrandt, K. Merz, G. Dyker, Chem. Commun. 2006, 661-662;
24. for other gold-catalyzed hydroamidations see: b) X.-Y. Liu, C.-H. Li, C.-M. Che, Org. Lett. 2006, 8, 2707-2710;
25. c) J. Zhang, C.-G. Yang, C. He, J. Am. Chem. Soc. 2006, 128, 1798-1799.
26. J. S. Ryu, G. Y. Li, T. J. Marks, J. Am. Chem. Soc. 2003, 125, 12584-12605.
27. a) G. A. Molander, S. K. Pack, Tetrahedron 2003, 59, 10581-10591;
28. b) G. A. Molander, S. K. Pack, J. Org. Chem. 2003, 68, 9214-9220.
29. a) A. B. J. Bracca, T. S. Kaufman, Tetrahedron 2004, 60, 10575-10610;
30. b) T. S. Kaufman, Tetrahedron: Asymmetry 2004, 15, 1203-1237.
31. J. D. Scott, R. M. Williams, Chem. Rev. 2002, 102, 1669-1730.
32. a) K. L. Rinehart, T. G. Holt, N. L. Fregeau, J. G. Stroh, P. A. Keifer, F. Sun, L. H. Li, D. G. Martin, J. Org. Chem. 1990, 55, 4512-4515;
33. b) Adis International Limited, Drugs R. & D. 2006, 7, 317-328;
34. c) J. Chen, X. Chen, M. Bois-Choussy, J. Zhu, J. Am. Chem. Soc. 2006, 128, 87-89.
35. See for examples: a) K. Okuda, Y. Kotake, S. Ohta, Biol. Pharm. Bull. 2006, 29, 1401-1403;
36. b) J. J. Luszczki, L. Antkiewicz-Michaluk, S. J. Czuczwar, Neuropharmacology 2006, 50, 133-142;
37. c) Y. Kotake, R. Taguchia, K. Okuda, Y. Sekiyaa, Y. Tasakic, M. Hirobec, S. Ohta, Brain Research 2005, 1033, 143-150;
38. d) J. Parrado, E. Absi, A. Ayala, A. Castano, J. Cano, A. Machado, J. Neurochem. 2000, 75, 65-71;
39. e) K. Ishiwata, Y. Koyanagi, K. Abe, K. Kawamura, K. Taguchi, T. Saitoh, J. Toda, M. Senda, T. Sano, J. Neurochem. 2001, 79, 868-876.
40. G. Bringmann, F. Pokorny, in The Alkaloids. Chemistry and Pharmacology, vol. 46 (Ed.: G. A. Cordell), Academic Press, New York, 1995, pp. 127-271.
41. a) C. B. de Koning, J. P. Michael, W. A. L. van Otterlo, Tetrahedron Lett. 1999, 40, 3037-3040;
42. b) C. B. de Koning, J. P. Michael, W. A. L. van Otterlo, J. Chem. Soc. Perkin Trans. 1 2000, 799-811.
43. a) C. B. de Koning, J. P. Michael, W. A. L. van Otterlo, Synlett 2002, 2065-2067;
44. b) C. B. de Koning, W. A. L. van Otterlo, J. P. Michael, Tetrahedron 2003, 59, 8337-8345.
45. For a preliminary account of the nBuLi-mediated hydroamination portion of this work see: a) W. A. L. van Otterlo, R. Pathak, C. B. de Koning, M. A. Fernandes, Tetrahedron Lett. 2004, 45, 9561-9563;
46. b) Experimental work performed by R. Pathak (PhD), P. Naicker (Hons.) and W. A. Thompson (Hons.).
47. For other examples of our work involving the imbedded THIQ structure see: a) W. A. L. van Otterlo, R. Pathak, C. B. de Koning, Synlett 2003, 1859-1861;
48. b) C. B. de Koning, J. P. Michael, R. Pathak, W. A. L. van Otterlo, Tetrahedron Lett. 2004, 45, 1117-1119;
49. c) A. N. C. Lötter, R. Pathak, T. S. Sello, M. A. Fernandes, W. A. L. van Otterlo, C. B. de Koning, Tetrahedron 2007, 63, 2263-2274.
50. C. B. de Koning, J. P. Michael, A. L. Rousseau, J. Chem. Soc. Perkin Trans. 1 2000, 787-797.
51. a) L. F. Tietze, O. Burkhardt, M. Henrich, Liebigs Ann./Recueil 1997, 1407-1413;
52. b) S. Hanessian, E. Demont, W. A. L. van Otterlo, Tetrahedron Lett. 2000, 41, 4999-5003;
53. c) J. L. Vicario, D. Badía, E. Domínguez, L. Carrillo, J. Org. Chem. 1999, 64, 4610-4616.
54. a) T. R. van den Ancker, L. M. Engelhardt, M. J. Henderson, G. E. Jacobsen, C. L. Raston, B. W. Skelton, A. H. White, J. Organomet. Chem. 2004, 689, 1991-1999;
55. b) H.-J. Oller, P. Kiprof, H. Schmidbaur, Z. Naturforsch., B: Chem. Sci. 1992, 47, 333-343;
56. c) C. A. Ogle, P. A. Riley, J. J. Dorchak, J. L. Hubbard, J. Org. Chem. 1988, 53, 4409-4412.
57. a) R. Lebeuf, F. Robert, Y. Landais, Org. Lett. 2005, 7, 4557-4560;
58. b) A. Ates, C. Quinet, Eur. J. Org. Chem. 2003, 1623-1626;
59. c) J. A. Seijas, M. P. Vázquez-Tato, C. Entenza, M. M. Martínez, M. G. Ónega, S. Veiga, Tetrahedron Lett. 1998, 39, 5073-5076;
60. for intermolecular examples see the next two references: d) C. G. Hartung, C. Breindl, A. Tillack, M. Beller, Tetrahedron 2000, 56, 5157-5162;
61. e) M. Beller, C. Breindl, Tetrahedron 1998, 54, 6359-6368.
62. J.-L. Panayides, R. Pathak, H. Panagiotopoulos, H. Davids, M. A. Fernandes, C. B. de Koning, W. A. L. van Otterlo, Tetrahedron 2007, 63, 4737-4747.
63. a) R. Pedrosa, C. Andrés, J. M. Iglesias, M. A. Obeso, Tetrahedron 2001, 57, 4005-4014;
64. b) L. F. Tietze, O. Burkhardt, Synthesis 1994, 1331-1336;
65. c) D. Tourwé, E. Mannekens, T. N. T. Diem, P. Verheyden, H. Jaspers, G. Tóth, A. Péter, I. Kertész, G. Török, N. N. Chung, P. W. Schiller, J. Med. Chem. 1998, 41, 5167-5176;
66. d) V. Kouznetsov, A. Palma, W. Rozo, E. Stashenko, A. Bahsas, J. Amaro-Luis, Synth. Commun. 2002, 32, 2965-2971;
67. e) B. Bonnaud, A. Carlessi, D. C. H. Bigg, J. Heterocycl. Chem. 1993, 30, 257-265.
68. CS Chem3D Ultra, Version 6.0, CambridgeSoft.com, Cambridge, MA, USA.
69. a) J. L. Vicario, D. Badía, L. Carrillo, J. Etxebarria, Curr. Org. Chem. 2003, 7, 1775-1792;
70. b) M. Chrzanowska, M. D. Rozwadowska, Chem. Rev. 2004, 104, 3341-3370.
71. a) J.-J. Youte, D. Barbier, A. Al-Mourabit, D. Gnecco, C. Marazano, J. Org. Chem. 2004, 69, 2737-2740;
72. b) D. Barbier, C. Marazano, C. Riche, B. C. Das, P. Potier, J. Org. Chem. 1998, 63, 1767-1772.
73. D. D. Perrin, W. L. F. Armarego, Purification of laboratory chemicals, Pergamon Press, London, 1988.